Dermata Therapeutics, Inc. Logo

Dermata Therapeutics, Inc.

Medical dermatology company developing and commercializing OTC skin care products.

DRMA | US

Overview

Corporate Details

ISIN(s):
US2498451085
LEI:
Country:
United States of America
Address:
3525 DEL MAR HEIGHTS RD., #322, 92130 SAN DIEGO

Description

Dermata Therapeutics is a medical dermatology company that has shifted its strategic focus to developing and commercializing scientifically-backed over-the-counter (OTC) pharmaceutical products. The company leverages its proprietary Spongilla technology, which combines natural elements with FDA-listed OTC ingredients to create differentiated skin care solutions. Its initial product is a once-weekly acne kit, supported by clinical validation from its Phase 3 START-1 trial. Dermata plans to expand its portfolio with product candidates for other common skin conditions, such as psoriasis and seborrheic dermatitis, aiming to provide patients with accessible and effective treatments to manage their skin health.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Dermata Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Dermata Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Dermata Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

L&C BIO Co., Ltd Logo
Develops and manufactures human tissue-based medical devices for regenerative medicine.
South Korea
290650
LEAP THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing targeted immuno-oncology therapies for cancer.
United States of America
LPTX
Legend Biotech Corp Logo
A biotech company that develops and commercializes novel cell therapies for diseases.
United States of America
LEGN
LENZ Therapeutics, Inc. Logo
A late-stage pharmaceutical company developing an eye drop to treat presbyopia.
United States of America
LENZ
Lexeo Therapeutics, Inc. Logo
A clinical-stage company developing AAV gene therapies for genetic diseases.
United States of America
LXEO
LEXICON PHARMACEUTICALS, INC. Logo
A biopharmaceutical company developing medicines using gene science and genetics.
United States of America
LXRX
Lidds AB Logo
Develops a drug delivery technology for local, controlled, and sustained release.
Sweden
LIDDS
LIFECORE BIOMEDICAL, INC. \DE\ Logo
A CDMO for sterile injectables and producer of non-animal-sourced hyaluronic acid.
United States of America
LFCR
Liminatus Pharma, Inc. Logo
A pre-clinical biopharma company developing immune-modulating cancer therapies.
United States of America
LIMN
Lineage Cell Therapeutics Inc. Logo
Develops allogeneic cell therapies from stem cells for degenerative diseases.
Israel
LCTX

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.